Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
dfwl28's Profile
Displaying 1-50 of 815 result(s).
CYDY CytoDyn Inc
10/05/2025 10:55:16 AM
Cytodyn Shareholders Community Mich (9)
CYDY CytoDyn Inc
09/30/2025 9:41:54 AM
Based on the positive data present (7)
CYDY CytoDyn Inc
09/19/2025 12:48:32 PM
Very favorable LL science and MoA o (9)
CYDY CytoDyn Inc
09/16/2025 5:46:49 PM
Excerpt: CYDY) ("CytoDyn" or the " (12)
CYDY CytoDyn Inc
09/15/2025 1:56:39 PM
>xcerpt : 11:00 am – 2nd Floor Sp
CYDY CytoDyn Inc
09/08/2025 2:10:01 PM
Katangolo: "...No mention of LL? ID (5)
CYDY CytoDyn Inc
09/04/2025 8:51:43 AM
CytoDyn Updates Time of Presentatio (3)
CYDY CytoDyn Inc
08/29/2025 9:31:50 AM
700mg Leronlimab Placebo 700mg Ope (1)
CYDY CytoDyn Inc
08/25/2025 5:59:31 PM
Open Waters = Underway. No longer a (3)
CYDY CytoDyn Inc
08/21/2025 11:30:37 AM
00:28:27> We're seeing evidence of (4)
CYDY CytoDyn Inc
08/19/2025 1:29:15 PM
Does LL positively impact enzyme S (15)
CYDY CytoDyn Inc
07/31/2025 12:46:45 PM
IL-6 cytokine -slow day "...Unlike
CYDY CytoDyn Inc
07/23/2025 9:55:10 AM
Side effects of Ipilimumab, also kn (4)
CYDY CytoDyn Inc
07/13/2025 7:58:30 PM
https://youtu.be/GIUu239FWMg (8)
CYDY CytoDyn Inc
07/02/2025 9:51:11 AM
Ohm: "... Bring in a PD-L1 or PD-1 (2)
CYDY CytoDyn Inc
06/22/2025 5:55:30 PM
Math and the immune complement syst (4)
CYDY CytoDyn Inc
06/20/2025 12:44:14 PM
Important confirmatory MoA paper fr (10)
CYDY CytoDyn Inc
06/13/2025 1:10:58 PM
OHM: LL and MYC? World-first "undru (2)
CYDY CytoDyn Inc
06/11/2025 3:29:13 PM
From the trial submitted June 9: Br (7)
CYDY CytoDyn Inc
06/10/2025 9:32:15 AM
No cures: “...cancer industrial c (4)
CYDY CytoDyn Inc
06/05/2025 6:34:58 PM
More on exposing hidden HIV. https: (5)
CYDY CytoDyn Inc
06/05/2025 9:15:09 AM
Would LL help HIV patients if it co (3)
CYDY CytoDyn Inc
06/03/2025 10:12:51 AM
"An individual went conservative on (12)
CYDY CytoDyn Inc
06/01/2025 10:37:08 AM
A Penny Stock To Watch In Challengi (5)
CYDY CytoDyn Inc
06/01/2025 10:15:35 AM
Pill slows breast cancer disease si
CYDY CytoDyn Inc
05/30/2025 10:03:01 AM
Bad AI reaches WH https://www.washi (4)
CYDY CytoDyn Inc
05/28/2025 5:36:14 PM
another link from stocktwits: https (3)
CYDY CytoDyn Inc
05/26/2025 5:02:31 PM
good short checkpoint explanation v (7)
CYDY CytoDyn Inc
05/22/2025 9:04:01 AM
The following AI response helped me (6)
CYDY CytoDyn Inc
05/18/2025 7:13:55 PM
Thanks to ESMO I think I understan (2)
CYDY CytoDyn Inc
05/16/2025 8:17:06 PM
OT: FDA endorses first-of-its-kind (3)
CYDY CytoDyn Inc
05/15/2025 5:22:23 PM
Click It! Support the algorithm. Al (3)
CYDY CytoDyn Inc
05/14/2025 12:05:48 PM
Ohm comment: "...66.6% aren't. What (4)
CYDY CytoDyn Inc
05/13/2025 4:07:52 PM
More inhibitor success in BRCA brea (2)
CYDY CytoDyn Inc
05/13/2025 1:30:04 PM
In MUO this is notable if not big s (6)
CYDY CytoDyn Inc
05/13/2025 8:52:14 AM
VANCOUVER, Washington, May 13, 2025 (2)
CYDY CytoDyn Inc
05/08/2025 8:41:21 AM
Ohm: "You can't fake that they are (8)
CYDY CytoDyn Inc
05/06/2025 9:03:21 AM
Thank You Cassandra. Very, very hel (3)
CYDY CytoDyn Inc
05/05/2025 1:58:13 PM
Hijacked AI excerpt from a post by (4)
CYDY CytoDyn Inc
05/05/2025 1:33:09 PM
Ohm: "A large rise from normal CCR5 (4)
CYDY CytoDyn Inc
05/05/2025 11:03:21 AM
Ken: Thanks for the reply. My first (3)
CYDY CytoDyn Inc
05/05/2025 10:09:03 AM
Interesting Ohm: "... As an example (5)
CYDY CytoDyn Inc
04/11/2025 5:52:29 PM
Excerpt: "Methods: By taking advant (12)
CYDY CytoDyn Inc
04/09/2025 1:32:50 PM
Thanks Ohm Excerpt: "Progression-f (6)
CYDY CytoDyn Inc
04/09/2025 9:33:19 AM
Ohm: "What I'd like to see is leron (4)
CYDY CytoDyn Inc
04/07/2025 8:43:21 PM
That study is from June 2022. Shoul (2)
CYDY CytoDyn Inc
04/03/2025 11:37:36 AM
CYDY is one of the exceptional gree (1)
CYDY CytoDyn Inc
03/26/2025 12:56:04 PM
Thanks Katangolo. It is very helpfu (1)
CYDY CytoDyn Inc
03/26/2025 10:23:24 AM
Can one of the brighter lights here (2)
CYDY CytoDyn Inc
03/24/2025 6:03:20 PM
"Docj Very helpful with complex CTC (3)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • WirelessCar Enhances Strategy in Japan with New Leadership
  • Alm. Brand A/S: Insights on Recent Share Buyback Activities
  • California Governor Celebrates Legal Win Against Federal Power
  • Challenges in Launching Jony Ive's Innovative AI Assistant
  • Impact Senior Living Enhances Services with New Facility
  • Freename's Pioneering Patent Bridges Web2 and Web3 Domains
  • Tesla Hints at New Model Y or Roadster: What's Coming Next?
  • Truecaller's adVantage: Revolutionizing AI with Engagement Insights
  • Minesto's Tidal Energy Innovations Showcased in Major Media
  • Danaos Corporation Plans Significant Senior Notes Offering
  • Tarkett Shares Update: Voting Rights and Capital Insights
  • Columbus A/S Highlights Recent Share Buyback Progress
  • Analyzing the Government Shutdown: Insights and Market Reactions
  • Truecaller Launches adVantage: Transforming Business Engagement
  • Onco3R Therapeutics Progresses with SIK3 Inhibitor Development
  • Advantest Revolutionizes Semiconductor Testing with AI Innovations
  • Nokia Unveils Innovative Tools for Enhanced Network Performance
  • Cutting-Edge Semiconductor Test Innovations by Advantest at SEMICON
  • Jean Eric Salata Set to Lead EQT as New Chairperson in 2026
  • Advantest Unveils Cutting-Edge Solutions at Major Tech Expo
  • Celebrating Culinary Excellence: S.Pellegrino Young Chef Awards
  • Olympus Partners with Gore: A New Era in EndoTherapy Solutions
  • Industry-Leading RZ/G3E SOM Platform Unveiled for Enhanced HMI
  • Investment Boosts Ukraine's Fintech-IT Group to Unicorn Status
  • Olympus Partners with Gore to Enhance Medical Device Offerings
  • Innovative Eco-Friendly Packaging Solutions Unveiled by LOG Pharma
  • Opensignal's New Broadband Solutions Transform ISP Customer Experience
  • Investment Milestone: First Ukrainian FinTech Unicorn Emerges
  • Christie’s International Real Estate Welcomes New Italian Partner
  • Nokia Partners with fibertime to Expand Fiber Broadband Access
  • Understanding the Latest Share Buyback News from RILBA
  • Important Notification on Fund Suspension by Danske Invest
  • Sigma Lithium's Sustainability Achievements and Operations Upgrade
  • Aarhus City Chooses cBrain F2 as a Digital Solution
  • Neurizon's Breakthrough: FDA Approves NUZ-001 for ALS Trials
  • Implantica Enhances Global Compliance with MDSAP Audit Success
  • NB Private Equity Partners Announces Successful Share Buyback
  • Fluor Corporation Investors: Join the Class Action Lawsuit
  • Falcon Oil & Gas Ltd. Reports Significant Shareholding News
  • Ford Faces Mechanics Shortages Amid Economic Challenges
  • Trogenix Secures $95M to Propel Innovative Cancer Therapies
  • Harness Therapeutics Unveils New MISBA Duo Platform with OVI
  • Neurizon Therapeutics Achieves Milestone with NUZ-001 Approval
  • Trogenix Secures Major Investment to Advance Cancer Therapies
  • Exploring the Future Growth of MEMS Microphones Market
  • TCM Group A/S: Shareholder Update and Company Overview
  • Exploring Stolt-Nielsen's New Bond Opportunities for Investors
  • Diversified Energy Company PLC Successfully Completes Buyback
  • Falcon Oil & Gas Ltd. Updates on Shareholdings and Growth
  • Elis Communicates Share Buyback Activities from Late September
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site